Registration for a live webinar on 'Gamma-delta T cells for immunotherapy of cancer' is now open.See webinar details
The End TB Strategy towards TB elimination 2
Published on November 30, 2021 52 min
A selection of talks on Microbiology
An introduction to the world of microbes
- Dr. David Westenberg
- Missouri University of Science and Technology, USA
Parasite immunity: introduction and Plasmodium
- Dr. Catarina Gadelha
- University of Nottingham, UK
Translating microbiome research to clinics: trends, directions and challenges
- Prof. Raj Eri
- University of Tasmania, Australia
Hello everyone, this is Mario Raviglione, I am a professor at the University of Milan where I teach global health and I'm also an honorary professor at the Queen Mary University of London. I used to be the director of the Global tuberculosis program at the World Health Organization in Geneva between 2003 and 2017. This talk is part 2 of my talk on the End TB Strategy.
As you remember from the previous talk I addressed in that one the burden of tuberculosis, the international targets and the progress towards them, the challenges to be faced today and finally the evolution of the global strategy of tuberculosis from DOTs to the End TB Strategy. In this talk I will be speaking exclusively about the End TB Strategy providing all details. The End TB Strategy
that as you heard in my previous part one was fully approved by the World Health Organization in 2014 and is a strategy that accompanies the sustainable development goals of the United Nations, it's part of it in a way, starting therefore in 2016 with the deadline in 2030. In this slide you see the vision the targets of the End TB Strategy. We have a vision of a world free of tuberculosis of a goal of ending the epidemic which coincides not by coincidence by the way with the sustainable development goals/aims of ending the epidemic. You see the three essential pillars of the strategy that I'm going to describe in detail, the first one is on integrated patient-centered TB care and prevention, if you like it's more the approach to the patient, it's the care part. Pillar 2 is on the policies instead, and speaks of the bold policies and the supportive systems that must be in place in a health system in a country to support the fight against tuberculosis. Finally pillar 3, is the one devoted to innovation and research, at the bottom there you see four layers, these are the four essential principles of the strategy, so the government has to provide the stewardship and has to be accountable, the second one is the coalition that is necessary with the civil society and the communities, the third one is the protection, the promotion of human rights of ethical behavior and finally of equity. Finally the last point there, the last principle is that of the adaptation of the strategy and the targets at the country level locally if you like, and the global collaboration that is necessary. On the right you have the targets, and the targets which I have described in part 1 of this talk and that I'm repeating and I'm focusing on those for 2030 that coincides with the sustainable development goals for 2030 for tuberculosis are the reduction, or number of TB deaths by 90 percent. A reduction in incidence of tuberculosis by 80 percent and what we would like to see starting actually in 2020 and in 2025 continuing and proceeding to 2030 is zero, is that number a zero, no family, no patient affected by TB should be facing catastrophic costs. These are the main, if you like indicators and therefore the targets related to those indicators that define the whole philosophy of the strategy.